Our results are inconsistent with the view that the anticonvulsant mechanism of action for CBD in Dravet syndrome is solely via blockade of GPR55. This evidence concerns the gene GPR55 and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.